The third clinical trials of Russian Covid 19 vaccine, Sputnik V has been published in the England medical journal, the Lancet (2021).
Sputnik effective rate is 92%, almost similar to American vaccines (Moderna and Biontech-Pfizer) which is 95%.
The advantages of Russian vaccine compared to American vaccines are following (in term of):
- price (about US$10 only)
- storage (able to be stored in regular fridge temperature)
Compared to UK’s vaccine, AstraZeneca, Sputnik V is clearly better in respect to effective rate.
If you read mainstream medias recently that South Africa government stop to conduct trials of AstraZeneca vaccine.
It is because the vaccine is not effective to control new strain from South Africa, called as 20H/ 501Y. V2 or B.1. 351.
However, the developer of Sputnik V believes that the vaccine works against Covid 19 new strains.
Whatever, people have plenty of choices, and hope, the vaccines are available in the market soon.